单核细胞特征与脑损伤后HSV再激活及神经功能恢复相关
研究纳入344例需有创机械通气的重型脑损伤患者,发现肺内HSV再激活见于HSV血清阳性者的39%,且独立关联6个月神经功能恢复不良(HR 1.90,95%CI 1.08-3.57)。单核细胞转录组特征可预测6个月神经功能结局(AUC 0.786,95%CI 0.593-0.978)。
要点
- 重型脑损伤机械通气患者中,HSV血清阳性者肺内HSV再激活率达39%。
- 肺HSV再激活独立关联6个月神经功能恢复不良(HR 1.90,95%CI 1.08-3.57)。
- 单核细胞特征可预测6个月神经功能结局(AUC 0.786,95%CI 0.593-0.978)。
核心结论
- 特定单核细胞特征与HSV再激活相关,并预测脑损伤后恢复不良。
- 疱疹病毒复制免疫控制改变研究不足,代表新治疗靶点。
研究设计与样本
- 前瞻性队列研究,收集重型脑损伤需有创机械通气患者的外周血单个核细胞。
- 系统检测气管吸出物中呼吸道HSV复制。
- 对第1天采集的单核细胞和CD4 T细胞进行染色质免疫沉淀测序、RNA测序及体外功能试验。
- 主要结局为6个月格拉斯哥结局扩展量表。
主要发现
- 344例重型脑损伤患者中,232例HSV血清阳性者里39%观察到肺HSV再激活。
- 肺HSV再激活独立关联6个月神经功能恢复不良(HR 1.90,95%CI 1.08-3.57)。
- 单核细胞转录组反应定义含721个基因的模块,包括PD-L1和CD80,富集转录因子Zeb2结合DNA基序。
- 该模块骨龄分析显示IFN-γ介导和抗病毒反应信号通路降低。
- 该单核细胞特征在验证队列中保留,预测6个月神经功能结局AUC 0.786(95%CI 0.593-0.978)。
临床怎么用
- 对重型脑损伤机械通气且HSV血清阳性患者,可考虑监测气管吸出物HSV复制。
- 单核细胞特征或有助于早期识别神经功能恢复不良高风险患者。
- 免疫控制疱疹病毒复制可能成为改善脑损伤后神经恢复的治疗靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Brain injury induces systemic immunosuppression, increasing the risk of viral reactivations and altering neurological recovery. Objectives: To determine if systemic immune alterations and lung replication of herpesviridae are associated and can help predict outcomes after brain injury. Methods: We collected peripheral blood mononuclear cells in patients with severe brain injury requiring invasive mechanical ventilation. We systematically searched for respiratory herpes simplex virus (HSV) replications in tracheal aspirates. We also performed chromatin immunoprecipitation sequencing, RNA-sequencing, and in vitro functional assays of monocytes and CD4 T cells collected on Day 1 to characterize the immune response to severe acute brain injury. The primary outcome was the Glasgow Outcome Scale Extended at 6 months. Measurements and Main Results: In 344 patients with severe brain injury, lung HSV reactivations were observed in 39% of the 232 patients seropositive for HSV and independently associated with poor neurological recovery at 6 months (hazard ratio, 1.90; 95% confidence interval, 1.08-3.57). Weighted gene coexpression network analyses of the transcriptomic response of monocytes to brain injury defined a module of 721 genes, including PD-L1 and CD80, enriched for the binding DNA motif of the transcriptional factor Zeb2 and whose ontogenic analyses revealed decreased IFN-γ-mediated and antiviral response signaling pathways. This monocyte signature was preserved in a validation cohort and predicted the neurological outcome at 6 months with good accuracy (area under the curve, 0.786; 95% confidence interval, 0.593-0.978). Conclusions: A specific monocyte signature is associated with HSV reactivation and predicts poor recovery after brain injury. The alterations of the immune control of herpesviridae replication are understudied and represent a novel therapeutic target.
引用
- Chaumette T, Cinotti R, Mollé A, et al. Monocyte Signature Associated with Herpes Simplex Virus Reactivation and Neurological Recovery after Brain Injury. Am J Respir Crit Care Med. 2022. PMID: 35486851. doi:10.1164/rccm.202110-2324OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。